AstraZeneca Sues Teva Over Seroquel Patent Challenge
The world's largest generic drug maker will head to court again to defend itself against allegations of patent infringement in yet another campaign to produce a generic version of AstraZeneca's best-selling...To view the full article, register now.
Already a subscriber? Click here to view full article